Characterization and crystal structure of tris(N′-ethyl-N-piperazinyl-carbodithioato-s,s′)cobalt(III) complex:: CO(S2CNC4H8NC2H5)3•3H2

被引:0
作者
Wang, Y [1 ]
Yan, LH [1 ]
机构
[1] Nanjing Univ Sci & Technol, Water Treatment Inst, Nanjing 210094, Jiangsu, Peoples R China
关键词
crystal structure; N-ethylpiperazine; bidentate ligand; cobalt complex;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The title compound has been prepared and characterized by elemental analyses, infrared and NMR spectra, and thermal analyses. The crystal and molecular structure of tris(N'-ethyl-N-piperazinly-carbodithioato-s,s')cobalt(III) complex, Co(S2CNC4H8NC2H5)(3)center dot 3H(2)O, was determined by X-ray diffraction methods. The compound crystallizes in trigonal system, space group R-3, with lattice parameters a= 1.37700(19) nm, b= 1.37700(19) nm, c=3.0090(6) nm, y=120 degrees, M-r=680.98, V=4.9411(14) nm(3), Z=6, D,=1.373 g/cm(3), F(000)=2160, R=0.0510 and wR= 0.1436. In the structure, central Co atom coordination geometry is slightly distorted octahedron with the six S atoms from the three bidentate S2CNC4H8NC2H5 ligands. The octahedron is distorted resulting from forced configuration of the four-membered chelate ring. The six Co-S bond distances are in the range of 0.22682(13)-0.22703(14) run. The IR and NMR spectral data are in agreement with the structural data. The thermal analytical data indicate that it decomposed completely at the temperature of 799.97 degrees C, leaving CoS.
引用
收藏
页码:843 / 846
页数:4
相关论文
共 17 条
[1]   SYNTHESES OF DINUCLEAR GOLD(I) RING COMPLEXES CONTAINING 2 DIFFERENT BRIDGING LIGANDS - CRYSTAL-STRUCTURE OF [AU2(MU-(CH2)2PPH2)(MU-S2CNET2)] [J].
BARDAJI, M ;
CONNELLY, NG ;
GIMENO, MC ;
JIMENEZ, J ;
JONES, PG ;
LAGUNA, A ;
LAGUNA, M .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1994, (08) :1163-1167
[2]   ISOTOPIC INFRARED STUDY OF SOME NICKEL(II) AND COPPER(II) COMPLEXES CONTAINING HETEROCYCLIC DITHIOCARBAMATE LIGANDS [J].
DESSEYN, HO ;
FABRETTI, AC ;
FORGHIERI, F ;
PRETI, C .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 1985, 41 (09) :1105-1108
[3]  
Gimeno MC, 1996, INORG CHIM ACTA, V249, P69
[4]  
GRINGERI A, 1988, CANCER RES, V48, P5708
[5]   DITIOCARB SODIUM (DIETHYLDITHIOCARBAMATE) THERAPY IN PATIENTS WITH SYMPTOMATIC HIV-INFECTION AND AIDS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY [J].
HERSH, EM ;
BREWTON, G ;
ABRAMS, D ;
BARTLETT, J ;
GALPIN, J ;
GILL, P ;
GORTER, R ;
GOTTLIEB, M ;
JONIKAS, JJ ;
LANDESMAN, S ;
LEVINE, A ;
MARCEL, A ;
PETERSEN, EA ;
WHITESIDE, M ;
ZAHRADNIK, J ;
NEGRON, C ;
BOUTITIE, F ;
CARAUX, J ;
DUPUY, JM ;
SALMI, LR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (12) :1538-1544
[6]  
RAYMOND J, 1976, J AM CHEM SOC, V8, P5159
[7]  
Riekkola M. L, 1979, KEMIA KEMI, V6, P525
[8]   STRUCTURE, THERMAL-STABILITY AND GAS-CHROMATOGRAPHIC BEHAVIOR OF SOME DIALKYLDITHIOCARBAMATE CHELATES OF PALLADIUM(II) [J].
RIEKKOLA, ML ;
PAKKANEN, T ;
NIINISTO, L .
ACTA CHEMICA SCANDINAVICA SERIES A-PHYSICAL AND INORGANIC CHEMISTRY, 1983, 37 (10) :807-816
[9]   PALLADIUM DITHIOCARBAMATES [J].
SCENEY, CG ;
MAGEE, RJ .
INORGANIC & NUCLEAR CHEMISTRY LETTERS, 1974, 10 (04) :323-330
[10]  
Sheldrick G. M., 1996, SADABS PROGRAM EMPIR